Prevalence of Non-Cytochrome P450-Mediated Metabolism in Food and Drug Administration-Approved Oral and Intravenous Drugs: 2006-2015. (Q38880368)

7 September 2017

title

Prevalence of Non-Cytochrome P450-Mediated Metabolism in Food and Drug Administration-Approved Oral and Intravenous Drugs: 2006-2015. (English)

1 reference

7 September 2017

Matthew A Cerny

1

1 reference

7 September 2017

publication date

15 April 2016

1 reference

Drug Metabolism and Disposition

7 September 2017

published in

1 reference

7 September 2017

volume

44

1 reference

7 September 2017

issue

8

1 reference

7 September 2017

page(s)

1246-1252

1 reference

Structure, catalytic mechanism, and evolution of the glutathione transferases

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

The pharmacological landscape and therapeutic potential of serine hydrolases

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Chemistry-enabled drug delivery (prodrugs): recent progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Species-specific metabolism of SGX523 by aldehyde oxidase and the toxicological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Concise review of the glutathione S-transferases and their significance to toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Orphans in the human cytochrome P450 superfamily: approaches to discovering functions and relevance in pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

The mammalian flavin-containing monooxygenases: molecular characterization and regulation of expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Cynomolgus monkey as a surrogate for human aldehyde oxidase metabolism of the EGFR inhibitor BIBX1382.

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Strategies for a comprehensive understanding of metabolism by aldehyde oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Aldo-keto reductases and bioactivation/detoxication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Optimizing levodopa pharmacokinetics with multiple tolcapone doses in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Pharmacogenetics of the alcohol dehydrogenase system

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

UDP-glucuronosyltransferases and clinical drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Olsalazine and 6-mercaptopurine-related bone marrow suppression: a possible drug-drug interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Inhibition of SN-38 glucuronidation by gefitinib and its metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Significant species difference in amide hydrolysis of GDC-0834, a novel potent and selective Bruton's tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Monoamine Oxidase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

The c-Met Tyrosine Kinase Inhibitor JNJ-38877605 Causes Renal Toxicity through Species-Specific Insoluble Metabolite Formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

The metabolic serine hydrolases and their functions in mammalian physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

The enzymatic basis of drug-drug interactions with systemic triazole antifungals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Carbonyl reductases: the complex relationships of mammalian carbonyl- and quinone-reducing enzymes and their role in physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Radiolabeled absorption, distribution, metabolism, and excretion studies in drug development: why, when, and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

The aldo-keto reductases (AKRs): Overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Uncovering the human methyltransferasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Aldehyde oxidase: an enzyme of emerging importance in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Inhibition of zaleplon metabolism by cimetidine in the human liver: in vitro studies with subcellular fractions and precision-cut liver slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: the SULT "pie".

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Use of in vitro drug metabolism data to evaluate metabolic drug-drug interactions in man: the need for quantitative databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90)

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

The effect of etoricoxib on the pharmacokinetics of oral contraceptives in healthy participants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

A novel reaction mediated by human aldehyde oxidase: amide hydrolysis of GDC-0834

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Sulfonation and molecular action

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Human UDP-glucuronosyltransferases: metabolism, expression, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Validated assays for human cytochrome P450 activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Carboxylesterase 1-mediated drug-drug interactions between clopidogrel and simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Predicting in vivo drug interactions from in vitro drug discovery data

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Carboxylesterase-2 is a highly sensitive target of the antiobesity agent orlistat with profound implications in the activation of anticancer prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

Reaction phenotyping: advances in the experimental strategies used to characterize the contribution of drug-metabolizing enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FDMD.116.070763

21 January 2018

Identifiers

DOI

10.1124/DMD.116.070763

1 reference

7 September 2017

1 reference